Evolution of uterine adenomyosis volume during and after GnRH antagonist (linzagolix) treatment: lessons for further clinical trials

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (7)

• Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis via openalex
• Partial suppression of estradiol: a new strategy in endometriosis management? via openalex
• Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
• Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis via openalex
• Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial via openalex
• W3203416324 via openalex
• W4295895755 via openalex

Cited by (10)

• Role of oral gonadotropin-releasing hormone antagonists in the management of uterine adenomyosis: a narrative review 2026
• The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
• Effects of Leuprorelin combined with Mirena on endocrine function, emotion, quality of life, and endometrial receptivity in patients with adenomyosis 2025
• Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2 2025
• Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal 2024
• The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications 2024
• Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
• Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
• Uterine adenomyosis: Is there an impact on in vitro fertilization outcomes? 2023
• Abnormal Uterine Bleeding in Reproductive Age Women: Role of Imaging in the Diagnosis and Management 2023

Source provenance

europepmc

last seen: 2026-10-14T06:08:39.101224+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-10-14T06:07:46.192524+00:00